Study to check whether a new topical gel can reduce swelling and hardness of surgical wounds after obstetric and gynaecological operations

Topical antioxidant- proteolytic gel for reduction of post operative wound induration - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103979

Enrollment

100

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O9A- Maternal malignant neoplasms, traumatic injuries and abuse classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: topical gel local application , 2 finger tip units of gel: Standard wound care + topical antioxidant-proteolytic gel twice daily for 7 10 days. Control Intervention1: nil: Standard post

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 18 60 years,Postoperative obstetric or gynaecological patients with wound induration,Willing to provide informed consent

Exclusion criteria

Exclusion criteria: Hypersensitivity to gel components,Infected or necrotic wounds,Systemic disorders affecting healing,Non-surgical pregnant/lactating women.

Design outcomes

Primary

Measure	Time frame
Reduction in wound induration diameter measured using standardized clinical grading scaleTimepoint: day 7 post intervention	—

Secondary

Measure	Time frame
Pain score reduction (VAS scale) Reduction in erythema and edema Patient satisfaction score Safety and adverse effects.Timepoint: day 7 post intervention	—

Countries

India

Contacts

Public ContactDr Parimala

Saveetha medical college hospital

parimalachats2002@yahoo.com9840281506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026